Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CLOV holding history

Clover Health Investments, Corp. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLOV overviewAll 13F holders of CLOVFull Q2 2026 holdings

Shares (Q2 2026)
409,450
Value
$2.15M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CLOV by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026409,450$2.15M<0.1%−1,358,349−76.8%ReducedHolders
Q1 20261,767,799$3.11M<0.1%+452,475+34.4%AddedHolders
Q4 20251,315,324$3.09M<0.1%−966,789−42.4%ReducedHolders
Q3 20252,282,113$6.98M<0.1%+1,388,761+155.5%AddedHolders
Q2 2025893,352$2.49M<0.1%+362,449+68.3%AddedHolders
Q1 2025530,903$1.91M<0.1%+359,585+209.9%AddedHolders
Q4 2024171,318$539.7K<0.1%+138,772+426.4%AddedHolders
Q3 202432,546$91.8K<0.1%−39,194−54.6%ReducedHolders
Q2 202471,740$88.2K<0.1%−170,752−70.4%ReducedHolders
Q1 2024242,492$192.5K<0.1%+117,503+94.0%AddedHolders
Q4 2023124,989$119.0K<0.1%+72,420+137.8%AddedHolders
Q3 202352,569$56.8K<0.1%+46,843+818.1%AddedHolders
Q2 20235,726$5.14K<0.1%+2,226+63.6%AddedHolders
Q1 20233,500$2.96K<0.1%−25,267−87.8%ReducedHolders
Q4 202228,767$26.8K<0.1%+25,098+684.1%AddedHolders
Q3 20223,669$6.00K<0.1%−31,504−89.6%ReducedHolders
Q2 202235,173$75.0K<0.1%+22,914+186.9%AddedHolders
Q1 202212,259$44.0K<0.1%+11,959+3,986.3%AddedHolders
Q4 2021300$1.00K<0.1%−8,321−96.5%ReducedHolders
Q3 20218,621$64.0K<0.1%−2,943−25.4%ReducedHolders
Q2 202111,564$154.0K<0.1%−13,381−53.6%ReducedHolders
Q1 202124,945$189.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.